Health Technology · Pharmaceuticals: Major · NSE: ORCHPHARMA · data 2026-10-09

Orchid Pharma Limited

Health check: Average (4.1/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹983.95

Market cap

₹5,877 cr

P/E

575.3

P/B

—

ROE

1.7%

ROCE

0.4%

Debt / equity

0.28

Dividend yield

0.00%

1-year return

35.0%

52-week high

₹1,143.5

52-week low

₹480

Operating margin

0.3%

Growth

Revenue (last 12 months)	₹943 cr
Net profit (last 12 months)	₹9 cr
Sales growth, 3 years (yearly)	6.8%
Profit growth, 3 years (yearly)	-23.7%

Similar companies

Sanofi India Limited (SANOFI) · Innova Captab Limited (INNOVACAP) · Sun Pharma Advanced Research Co. Ltd. (SPARC) · Senores Pharmaceuticals Ltd. (SENORES) · FDC Ltd. (FDC)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open ORCHPHARMA in NSE Scanner →